Vial
company
About
Vial is a clinical trial infrastructure company delivering dramatically faster and more efficient trials.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $67M
- Industries
- Biotechnology,Clinical Trials,Health Care,Medical
- Founded date
- Jan 1, 2020
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Vial was founded to execute on a mission to reimagine clinical trials by delivering faster and more efficient trials for sponsors. Vial’s powerful technology platform delivers faster, more efficient trials that are up to 50% cheaper.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$101M
Vial has raised a total of
$101M
in funding over 2 rounds. Their latest funding was raised on
Nov 30, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 30, 2022 | Series B | $67M | 1 |
General Catalyst
|
— | Detail |
| Nov 30, 2022 | Series A | $34M | 1 |
General Catalyst
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
4
0
Vial has made 4 investments. Their most recent investment was on
Sep 27, 2019, when Eight Sleep raised 0.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 27, 2019
Eight Sleep
|
Pre-seed | — | Consumer Electronics | — |
|
Oct 27, 2010
DataStax
|
Series A | $2.70M | Information Technology | — |
|
Oct 15, 2010
Uber
|
Angel | $1.25M | Logistics | — |
|
Aug 1, 2010
StorkBrokers.com
|
Pre-seed | — | Children | — |
Investors
Number of Lead Investors
Number of Investors
2
1
Vial is funded by 1 investors.
General Catalyst
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
General Catalyst
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
